Department of Physical Education and Sport Sciences, Faculty of Sport Science, Ferdowsi University of Mashhad, Mashhad, Iran.
Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences (BUMS), Birjand, Iran.
Endocr Metab Immune Disord Drug Targets. 2021;21(10):1912-1919. doi: 10.2174/1871530320666201208105844.
In this study, we explored the impacts of moderate-to-high intensity resistance circuit training (MHRCT) and Ursolic acid (UA) supplementation to improve these pathological changes in young older obese women (women between the ages of 50 and 70).
The study included twenty-five young older women (age > 50 years and ≤70 years) with stage I-II obesity (BMI ≥ 30 and <40 kg/m2), who received eight weeks placebo with MHRCT, and MHRCT with UA supplementation. UA or placebo orally was ingested as a capsule three times per day for eight weeks. The following parameters were evaluated post- and pre-intervention. Data were analyzed using ANOVA with repeated measures.
Interleukin-15 (IL-15), Interleukin-6 (IL-6), Insulin, and HOMA-IR decreased significantly in the placebo and UA groups versus control, but the UA group significantly decreased compared with the placebo (p<0.05). In turn, the Brain-Derived Neurotrophic Factor (BDNF) and Irisin levels showed a significant increase in the placebo and UA groups versus control. However, the BDNF in the UA group significantly increased compared with the placebo (p < 0.05).
We demonstrated that applying resistance training can reverse the pathological changes that may occur with aging and a sedentary lifestyle. Our results showed that UA could enhance the effects of this type of exercise. Therefore, a combination of the resistance training program and UA supplementation may be considered as a novel and influential intervention to metabolic derangements and may also decrease the burden associated with this condition.
在这项研究中,我们探讨了中高强度阻力循环训练(MHRCT)和熊果酸(UA)补充对改善年轻肥胖老年女性(50 至 70 岁女性)这些病理变化的影响。
该研究纳入了 25 名患有 I 期至 II 期肥胖症(BMI≥30 且<40kg/m2)的年轻老年女性(年龄>50 岁且≤70 岁),她们接受了 8 周安慰剂联合 MHRCT 以及 MHRCT 联合 UA 补充治疗。UA 或安慰剂通过胶囊口服,每日 3 次,共 8 周。在干预前后评估以下参数。采用重复测量方差分析对数据进行分析。
与对照组相比,安慰剂和 UA 组的白细胞介素 15(IL-15)、白细胞介素 6(IL-6)、胰岛素和 HOMA-IR 显著降低,但 UA 组与安慰剂组相比显著降低(p<0.05)。相反,脑源性神经营养因子(BDNF)和鸢尾素水平在安慰剂和 UA 组与对照组相比均显著升高。然而,UA 组的 BDNF 水平与安慰剂组相比显著升高(p<0.05)。
我们证明了应用阻力训练可以逆转衰老和久坐不动的生活方式可能导致的病理变化。我们的结果表明,UA 可以增强这种类型运动的效果。因此,阻力训练计划和 UA 补充的结合可能被认为是一种新的、有影响力的干预措施,可以改善代谢紊乱,并可能减轻与这种情况相关的负担。